{"disease":{"id":"metastatic-or-locally-advanced-pd-l1-positive-urothelial-cancer","name":"metastatic or locally advanced pd l1 positive urothelial cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03891238","title":"Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Consorzio Oncotech","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}